文献速递肝病

自身免疫性肝病中的调节性T细胞

Regulatory T cells in autoimmune liver diseases.
PubMed 文献 · Gut · 2026-10-01

本文综述自身免疫性肝病(AILD)中调节性T细胞(Treg)的改变,整合人类研究与临床前模型证据,揭示Treg丰度、表型和功能在疾病亚型、分期及组织间存在异质性,并探讨靶向Treg的治疗策略及转化挑战。

要点

  • Treg在AILD中功能与丰度改变,外周与肝脏微环境存在差异
  • Treg异质性见于不同疾病亚型、分期和组织 compartment
  • 靶向Treg的治疗策略包括恢复其丰度和功能及疾病特异性调节

核心结论

  • AILD中Treg改变具有疾病依赖性和背景依赖性,需整合多维度证据理解。

研究设计与样本

  • 综述整合人类研究和临床前模型证据,聚焦AILD中Treg改变。

主要发现

  • Treg在AILD中功能与丰度改变,外周与肝脏环境存在显著差异。
  • Treg丰度、表型和功能在疾病亚型、分期及组织间存在异质性。
  • 局部免疫微环境与肠-肝轴影响Treg稳定性和功能。

临床怎么用

  • 当前和新兴Treg靶向策略包括恢复Treg丰度和功能及疾病特异性调节。
  • 临床转化面临挑战,需优先开展机制和转化研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autoimmune liver diseases (AILDs), including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis and IgG4-related sclerosing cholangitis, are characterised by immune dysregulation that adversely affects the hepatocytes or bile ducts. Regulatory T cells (Tregs), which are pivotal for immune tolerance, display altered function and abundance across these disorders, with notable differences between peripheral and hepatic environments. This review synthesises current evidence on disease-specific Treg alterations across AILDs, integrating findings from human studies and preclinical models. We highlight heterogeneity in Treg abundance, phenotype and function across disease subtypes, stages and tissue compartments, while examining the influence of the local immune microenvironment and gut-liver axis on Treg stability and function. We further evaluate current and emerging Treg-targeted therapeutic strategies, ranging from restoration of Treg abundance and function to disease-specific modulation of Treg responses, together with the major challenges to their clinical translation. By integrating these findings, we provide a disease-dependent and context-dependent framework for understanding Treg dysregulation in AILDs and identify key priorities for future mechanistic and translational research.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Chen S, Zhang H, Huang H, et al. Regulatory T cells in autoimmune liver diseases. Gut. 2026. PMID: 42823333. doi:10.1136/gutjnl-2026-338812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。